Dr. Sandeep has 11+ years of experience in pharmaceutical industry. His business acumen, entrepreneurial zeal, organizational skills and managerial abilities have enabled company to grow leaps and bounds and spread its wings across the globe.

He set out with a vision to create a global pharmaceutical company. Under his able and dynamic leadership, Oniosome has grown rapidly to attain newer milestones and the highest level of performance. He is the principal architect for the progress of the organization.

Dr. Sandeep is M. Pharm (Pharmaceuticals) graduate for about one decades of experience across Research & Development. He is well versed with the overall management of the company and possesses vast amount of hands-on experience in research and formulation development.

Dr. Kamireddy worked as Research Scientist at NBI Biosciences and was involved in R&D activities that relates to extraction and purification of plant actives at CSIR-CFTRI, NBI collaborator. ​

Dr. Kiran has 5-Years of lab experience and holds a PhD in the field of Biotechnology and extensively worked in the field of botanical cultivation and testing., Kiran works on the focus of plant extracts, isolation, and purification of bioactive compounds. Presently he is working as a social innovator in BIRAC sponsored project.

Dr. Saxena is working as Head R&D at Chemzin Biotox Research Institute Pvt Ltd with demonstrated excellence in Pre-clinical Research and Innovative Healthcare Product development. He has more than 15 years of experience in endocrinology, molecular genetics, and Invitro cell culture studies.

He has worked with reputed Government organizations, universities, CRO’s and journal publishing companies. He was involved in NBI’s Cholesterol formulation animal studies including development of animal model, histopathology and biochemical investigations.

Dr. Ramakrishnan serves as Principal Scientist of CSIR-Indian Institute of Toxicology Research, Lucknow at Computational Toxicology Facility, Toxicoinformatics Research and leading BIRAC-BioNEST supported Centre for Innovation and Translational Research (CITAR), and Environmental Monitoring and Intervention Hub (DSIR-CRTDH-IITR).

Dr. Partha earned his PhD from CLRI, University of Madras and he served as a scientist with highly reputed institutions like the Lawrence Berkeley National Labs, Los Alamos National Laboratory, and Sandia National Laboratories, USA. He has more than 20 years of research experience in applied biochemistry to unravel important issues in human health and the environment. His lab is currently involved in the development of AI & Machine Learning based computational toxicity models, biomolecular simulations, databases, and developing innovative predictive approaches relevant to translational research.

Dr Pal is working as a Lab Director at AAL Biosciences Research Pvt Ltd with a demonstrated history of working around drug development including pre-clinical efficacy and toxicology testing using different animal models in the area of various chronic diseases for more than 15 years along with clinical regulatory affairs, pharmacovigilance/ safety, R&D quality, biostatistics. He also has technical expertise in Pharmaceutical, Clinical Biochemistry, Molecular Biology, Clinical Pathology, Quality Management. He was involved with NBI for pre-clinical safety and efficacy study of Cholesterol formulation.